🔎 Trials Near Me

Gara Jalqabaatti › Kansarii Colorectal › Connecticut

Qorannoo klinikaalii Kansarii Colorectal Connecticut keessatti

Qorannoo 23 Kansarii Colorectal f Connecticut keessatti hirmaatuu jiru.

Magaalota Connecticut keessatti

Takkalaa qorannoo (Ingiliffa)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Yale Cancer Center, New Haven
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04585750

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  • Exelixis Clinical Site #62, New Haven
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT05176483

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

  • Yale University School of Medicine, New Haven
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06324357

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

  • Yale Cancer Center, New Haven
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07578571

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

  • Yale University School Of Medicine, New Haven
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06662786

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

  • Kivu Trial Site, New Have
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07229313

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

  • Yale-New Haven Hospital-Yale Cancer Center, New Haven
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06445062

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

  • Yale Cancer Center, New Haven
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07349537

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  • Yale University School of Medicine - Yale Cancer Center, New Haven
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT05786924

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

  • Hartford Hospital, Hartford
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07284849

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

  • Yale Cancer Center, New Haven
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT04929223

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

  • Clinical Study Site, Hartford
  • Clinical Study Site, New Haven
  • Clinical Study Site, Norwich
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT07228832

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

  • Yale University, New Haven
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT06992258

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • Yale University School of Medicine, New Haven
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT05919264

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

  • Eastern Connecticut Hematology and Oncology Associates, Norwich
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT07397338

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

  • Yale University, New Haven
  • Smilow Cancer Hospital Care Center-Trumbull, Trumbull
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT05691491

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

  • Yale Comprehensive Cancer Center, New Haven
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT07169734

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

  • Smilow Cancer Hospital (Yale University), New Haven
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Wax-2026 · NCT06040541

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

  • Yale University, New Haven
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Wax-2026 · NCT06917079

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

  • Yale University, Yale Cancer Center, New Haven
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Bit-2026 · NCT06395519

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.